Delivery Order SPE2DB20D1100-SPE2DB24FC7L8

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $7,730.01, for the delivery of Losartan-HCTZ 100-12.5 mg tablets. The contract has a period of performance through June 3, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has a firm fixed price of $6,573.14 and a completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,489.90, is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The contract is a firm fixed-price delivery order with a completion date of March 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,544.11, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. This is a firm-fixed-price delivery order contract with a performance period extending to May 29, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The contract has a firm fixed price of $30,541.60 and a period of performance through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.32, is for the delivery of 4567828124 - LOSARTAN-HCTZ 100-12.5 MG TAB 1000S, with a completion date of April 8, 2025. The contract is a Delivery Order under a Firm Fixed Price structure and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,596.20, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,295.33, is a delivery order for Losartan-HCTZ 100-12.5 mg tablets, a cardiovascular medication. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,935.62, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,656.91, is for the delivery of Losartan-HCTZ 100-25 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 28, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC7L8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,486.20, is a delivery order for Losartan-HCTZ 100-12.5 mg tablets. The contract has an ultimate completion date of July 16, 2024 and is a firm fixed-price contract.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is a task order or delivery order issued under this larger IDC contract. No set-aside designation was used for this award.

Generated 5/17/25, 9:45 AM